]>
IRCT20130722014106N9 IRCT 2021-11-30 Kermanshah University of Medical Sciences Effect of oral syrup and intranasal spray of Falcaria Vulgaris plant in patients with Covid-19 Comparison of the effectiveness of oral syrup and intranasal spray of Falcaria Vulgaris plant on patients with Covid-19 2021-11-22 anticipated 100 Complete https://irct.ir/trial/56977 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Using random blocking method (Block Randomization ) with 4 blocks and a ratio of 1: 1 are allocated to the treatment and control groups. (For 4 blocks there will be six different modes: 1.TTCC 2.TCTC 3.TCCT 4.CCTT 5.CTTC 6.CTCT). Random numbers will be created with the help of a computer and a statistics consultant. For numbers between 0 and 1.6, combination 1 (TTCC), numbers between 1.6 and 2.6, combination 2 (TCTC), etc. are divided into two groups of 50 people. Patients based on randomized block allocation method classified according to age range (20 years and later) and gender (male, female) in two groups with 50 people (25 males and 25 females) with Herbal medicine treatment (treatment) and routine treatment (control), Blinding description: Herbal medicine and placebo packaging is prepared with a label with code B or A. Other specifications on the labels are the same. Physicians, nurses, patients, data collectors, and those evaluating the outcome are unaware of the drug and placebo group. Patients are aware that they are in either the herbal group or the placebo group, but they do not know the type of group they are in. 3 COVID-19. Intervention 1: Intervention group: Patients in this group, in addition to receiving standard medications, use a syrup or nasal spray prepared from the mountain ghaziani plant, which is dried under normal conditions and prepared as a syrup and nasal spray three times a day for a week. Intervention 2: Control group: Routine treatment according to the latest update of the new national coronavirus treatment guidelines. Yes - There is a plan to make this available What will be shared: The main consequences are shared after the intervention in the disease When: One year after the publication of the results To whom: Researchers, doctors and students Conditions: For the use of other researchers Where to obtain: Correspond with the project manager. Phone: 08337272049 Email: hossein.amirii@yahoo.com How to obtain: Request via email Comments:
public Hossein Amiri
Naghlieh Street - Imam Khomeini Hospital, Kermanshah
kermanshah Iran (Islamic Republic of) 6718743161 008337272049 hossein.amirii@yahoo.com Kermanshah University of Medical Sciences scientific Hossein Amiri
Naghlieh Street - Imam Khomeini Hospital, Kermanshah
kermanshah Iran (Islamic Republic of) 6718743161 008337272049 hossein.amirii@yahoo.com Kermanshah University of Medical Sciences Iran (Islamic Republic of) Confirmation of coronavirus infection by CT scan of the chest and PCR test Age 20 to 70 years Willingness to cooperate in the study and completion of informed written consent 20 years 70 years Both pregnant women children Elderly (people over 70) People who use mechanical ventilation People undergoing chemotherapy People who receive corticosteroids are excluded from the study U07.1 Covid-19 Treatment - Drugs Treatment - Drugs Intervention group: Patients in this group, in addition to receiving standard medications, use a syrup or nasal spray prepared from the mountain ghaziani plant, which is dried under normal conditions and prepared as a syrup and nasal spray three times a day for a week. Control group: Routine treatment according to the latest update of the new national coronavirus treatment guidelines Blood oxygen saturation. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: Pulse oximeter. Rate of lung involvement. Timepoint: beginning and end of the study. Method of measurement: computed tomography scan. Number of breaths. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: Counting breaths per minute. Body temperature. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: thermometer and clinical examination. Dyspnea. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: clinical examination. Cough. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: clinical examination. Kermanshah University of Medical Sciences Approved 2021-10-19 Ethics committee of Kermanshah University of Medical Science Central building, Beheshti Blvd, Kermanshah University of Medical Science Kermanshah Kermanshah Iran (Islamic Republic of)